In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers

Tuberculosis (TB) remains the world's leading cause of morbidity and mortality. Although Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the only vaccine currently in use, its efficacy is highly variable. It has been suggested that early antigenic presentation is a pivotal event leading t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Ponte, C, Peres, L, Marinho, S, Lima, J, Siqueira, M, Pedro, T, De Luca, P, Cascabulho, C, Castello-Branco, L R, Antas, P R Z
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2014
Aiheet:
LICENSED VACCINES/Short Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514217/
https://ncbi.nlm.nih.gov/pubmed/25483636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.970954
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia